{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T21:43:48Z","timestamp":1773783828024,"version":"3.50.1"},"reference-count":7,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01 HD106590"],"award-info":[{"award-number":["R01 HD106590"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["STAR Protocols"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.xpro.2025.104269","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:32:24Z","timestamp":1765485144000},"page":"104269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Protocol for screening of small molecules in a CLN3 disease patient-specific iPSC-derived neuronal progenitor cell model"],"prefix":"10.1016","volume":"6","author":[{"given":"Ramu","family":"Venkatesan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4947-5782","authenticated-orcid":false,"given":"Paul C.","family":"Trippier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xpro.2025.104269_bib1","doi-asserted-by":"crossref","first-page":"18530","DOI":"10.1021\/acs.jmedchem.5c01369","article-title":"Discovery of Functionalized 1H-Benzo[d]imidazoles That Confer Protective Effects in a Phenotypic CLN3 Disease Patient-Derived iPSC Model","volume":"68","author":"Simeon","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.xpro.2025.104269_bib2","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.3390\/molecules26206235","article-title":"Patient-derived induced pluripotent stem cell models for phenotypic screening in the neuronal ceroid lipofuscinoses","volume":"26","author":"Morsy","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.xpro.2025.104269_bib3","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1021\/acsptsci.0c00077","article-title":"An iPSC-derived neuron model of CLN3 disease facilitates small molecule phenotypic screening","volume":"3","author":"Kinarivala","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.xpro.2025.104269_bib7","series-title":"Basic Cell Culture Protocols","author":"Helgason","year":"2005"},{"key":"10.1016\/j.xpro.2025.104269_bib4","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.stemcr.2017.04.013","article-title":"NEUROD1 instructs neuronal conversion in non-reactive astrocytes","volume":"8","author":"Brulet","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.xpro.2025.104269_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105120","article-title":"Metformin attenuates rotenone-induced oxidative stress and mitochondrial damage via the AKT\/Nrf2 pathway","volume":"148","author":"Katila","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.xpro.2025.104269_bib6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.brainres.2016.03.051","article-title":"Studying human disease using human neurons","volume":"1656","author":"Ahfeldt","year":"2017","journal-title":"Brain Res."}],"container-title":["STAR Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666166725006756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666166725006756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T18:04:06Z","timestamp":1773770646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666166725006756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2666166725006756"],"URL":"https:\/\/doi.org\/10.1016\/j.xpro.2025.104269","relation":{},"ISSN":["2666-1667"],"issn-type":[{"value":"2666-1667","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protocol for screening of small molecules in a CLN3 disease patient-specific iPSC-derived neuronal progenitor cell model","name":"articletitle","label":"Article Title"},{"value":"STAR Protocols","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xpro.2025.104269","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104269"}}